FOXO3 and osteosarcoma: By analyzing the molecular mechanisms, the authors demonstrated that tomentosin-induced ROS upregulate FOXO3 and p27 expression, thus suggesting that FOXO3 upregulation controls G2/M phase cell cycle arrest through p27 overexpression after tomentosin treatment in an osteosarcoma cell line [24].